GFAP and central nervous system cancer: In addition, GFAP-Cre lines have been used to generate murine glioma models due to conditional deletion of tumor suppressor genes [22]–[24] and astrocytomas form with high penetrance in mice in which activated Ras is expressed from the GFAP promoter [25].